Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Glaucoma, Open-AngleOcular Hypertension
- Interventions
- First Posted Date
- 2011-02-08
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Allergan
- Target Recruit Count
- 125
- Registration Number
- NCT01291108
Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Phase 3
Withdrawn
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-01-26
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- Allergan
- Registration Number
- NCT01284166
Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines
Phase 4
Completed
- Conditions
- Glabellar Lines
- Interventions
- Biological: botulinum toxin type A
- First Posted Date
- 2011-01-06
- Last Posted Date
- 2019-01-29
- Lead Sponsor
- Allergan
- Target Recruit Count
- 224
- Registration Number
- NCT01271452
Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis
Phase 3
Completed
- Conditions
- Rhinitis, Allergic, SeasonalConjunctivitis, Allergic
- Interventions
- First Posted Date
- 2010-12-10
- Last Posted Date
- 2012-01-25
- Lead Sponsor
- Allergan
- Target Recruit Count
- 129
- Registration Number
- NCT01258309
Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- Glaucoma, Open-AngleOcular Hypertension
- Interventions
- First Posted Date
- 2010-12-06
- Last Posted Date
- 2012-11-07
- Lead Sponsor
- Allergan
- Target Recruit Count
- 164
- Registration Number
- NCT01253902
Inter-rater and Intra-rater Reliability Study of the Global Eyelash Assessment Scale for Assessment of Overall Eyelash Prominence
Completed
- Conditions
- Healthy Volunteers
- First Posted Date
- 2010-12-02
- Last Posted Date
- 2012-09-28
- Lead Sponsor
- Allergan
- Target Recruit Count
- 68
- Registration Number
- NCT01252147
Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated
Phase 4
Completed
- Conditions
- Glaucoma, Open-Angle
- Interventions
- First Posted Date
- 2010-11-18
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- Allergan
- Target Recruit Count
- 81
- Registration Number
- NCT01243567
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Ocular HypertensionGlaucoma, Open-Angle
- Interventions
- Drug: bimatoprost/brimonidine tartrate/timolol ophthalmic solution (Triple Combination Therapy)Drug: Fixed Combination 0.2% brimonidine tartrate/0.5% timolol ophthalmic solution
- First Posted Date
- 2010-11-16
- Last Posted Date
- 2014-09-10
- Lead Sponsor
- Allergan
- Target Recruit Count
- 192
- Registration Number
- NCT01241240
A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne
Phase 4
Completed
- Conditions
- Acne Vulgaris
- Interventions
- Drug: Clindamycin/benzoyl peroxide plus Adapalene
- First Posted Date
- 2010-11-01
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Allergan
- Target Recruit Count
- 286
- Registration Number
- NCT01231334
Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects
- First Posted Date
- 2010-10-27
- Last Posted Date
- 2019-01-29
- Lead Sponsor
- Allergan
- Target Recruit Count
- 62
- Registration Number
- NCT01229423
© Copyright 2025. All Rights Reserved by MedPath